The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gafarov V.V.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Gromova E.A.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Gubina M.A.

Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences

Gagulin I.V.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Maksimov V.N.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences

Gafarova A.V.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

The association of polymorphisms of the serotonin transporter gene SLC6A4 with depression

Authors:

Gafarov V.V., Gromova E.A., Gubina M.A., Gagulin I.V., Maksimov V.N., Gafarova A.V.

More about the authors

Read: 1900 times


To cite this article:

Gafarov VV, Gromova EA, Gubina MA, Gagulin IV, Maksimov VN, Gafarova AV. The association of polymorphisms of the serotonin transporter gene SLC6A4 with depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(2):135‑139. (In Russ.)
https://doi.org/10.17116/jnevro2024124021135

Recommended articles:
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12

References:

  1. World Health Organization. World Heal Organization; 2017. [(accessed on 1 October 2020)]. Depression and Other Common Mental Disorders: Global Health Estimates. https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf;jsessionid=96DC05048E48EBF0BFF55ADF1A28292A?sequence=1
  2. Iancu SC, Wong YM, Rhebergen D, et al. Long-term disability in major depressive disorder: A 6-year follow-up study. Psychol Med. 2019;50:1644-1652. https://doi.org/10.1017/S0033291719001612
  3. Flint J, Kendler KS. The genetics of major depression. Neuron. 2014;81(3):484-503.  https://doi.org/10.1016/j.neuron.2014.01.027
  4. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289:3095-3105. https://doi.org/10.1001/jama.289.23.3095
  5. Scott J, Palmer S, Paykel E, et al. Use of cognitive therapy for relapse prevention in chronic depression. Cost-effectiveness study. Br J Psychiatry. 2003;182:221-227.  https://doi.org/10.1192/bjp.182.3.221
  6. Vöhringer PA, Ghaemi SN. Solving the antidepressant efficacy question: effect sizes in major depressive disorder. Clin Ther. 2011;33(12):B49-61.  https://doi.org/10.1016/j.clinthera.2011.11.019
  7. Norkeviciene A, Gocentiene R, Sestokaite A, et al. A Systematic Review of Candidate Genes for Major Depression. Medicina (Kaunas). 2022;58(2):285.  https://doi.org/10.3390/medicina58020285
  8. NCBI SLC6A4 Solute Carrier Family 6 Member 4 [Homo Sapiens (Human)] [Internet] [(accessed on 10 June 2020)];2019. https://www.ncbi.nlm.nih.gov/gene/6532
  9. Chen F-X, Chen X-S, Guo J-C, et al. Serotonin transporter-linked polymorphic region genotypes in relation to stress conditions among patients with papillary thyroid carcinoma. Int J Clin Exp Pathol. 2019;12:968-977. 
  10. Fratelli C, Siqueira J, Silva C, et al. 5HTTLPR Genetic Variant and Major Depressive Disorder: A Review. Genes (Basel). 2020;11(11):1260. https://doi.org/10.3390/genes11111260
  11. Palma-Gudiel H, Fañanás L. An integrative review of methylation at the serotonin transporter gene and its dialogue with environmental risk factors, psychopathology and 5-HTTLPR. Neurosci Biobehav Rev. 2017;72:190-209.  https://doi.org/10.1016/j.neubiorev.2016.11.011
  12. Iurescia S, Seripa D, Rinaldi M. Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: A Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants. Mol Neurobiol. 2015;53:5510-5526. https://doi.org/10.1007/s12035-015-9409-6
  13. Hu X-Z, Lipsky RH, Zhu G, et al. Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive Disorder. Am J Hum Genet. 2006;78:815-826.  https://doi.org/10.1086/503850
  14. World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe; 1988.
  15. Bühl A, Zöfel P. SPSS Version 10. Einführung in die moderne Datenanalyse unter Windows. 2005;608. 
  16. Ivanets NN, Kinkulkina MA, Tikhonova YG, et al. Relationship between the 5-HTTLPR polymorphism of the serotonin transporter gene and the effectiveness and tolerability of selective serotonin reuptake inhibitors. Journal of Neurology and Psychiatry S.S. Korsakov. 2016;116(2):46-51. (In Russ.). https://doi.org/10.17116/jnevro20161162146-51
  17. Kostić M, Munjiza A, Pesic D, et al. A pilot study on predictors of brainstem raphe abnormality in patients with major depressive disorder. J Affect Disord. 2017;209:66-70.  https://doi.org/10.1016/j.jad.2016.11.034
  18. Fleurkens P, Van Minnen A, Becker ES, et al. Automatic approach-avoidance tendencies as a candidate intermediate phenotype for depression: Associations with childhood trauma and the 5-HTTLPR transporter polymorphism. PLoS ONE. 2018;13:e0193787. https://doi.org/10.1371/journal.pone.0193787
  19. Schneider I, Kugel H, Redlich R, et al. Association of Serotonin Transporter Gene AluJb Methylation with Major Depression, Amygdala Responsiveness, 5-HTTLPR/rs25531 Polymorphism, and Stress. Neuropsychopharmacology. 2017;43:1308-1316. https://doi.org/10.1038/npp.2017.273
  20. Tatham EL, Hall GBC, Clark D, et al. The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression. Eur Arch Psychiatry Clin Neurosci. 2016;267:135-147.  https://doi.org/10.1007/s00406-016-0702-9
  21. Tatham EL, Ramasubbu R, Gaxiola-Valdez I, et al. White matter integrity in major depressive disorder: Implications of childhood trauma, 5-HTTLPR and BDNF polymorphisms. Psychiatry Res Neuroimaging. 2016;253:15-25.  https://doi.org/10.1016/j.pscychresns.2016.04.014
  22. Basu A, Chadda R, Sood M, et al. A preliminary association study between serotonin transporter (5-HTTLPR), receptor polymorphisms (5-HTR1A, 5-HTR2A) and depression symptom-clusters in a north Indian population suffering from Major Depressive Disorder (MDD). Asian J Psychiatry. 2019;43:184-188.  https://doi.org/10.1016/j.ajp.2019.05.028
  23. Manoharan A, Shewade DG, Rajkumar RP, et al. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients. Eur J Clin Pharmacol. 2016;72:1215-1220. https://doi.org/10.1007/s00228-016-2099-9
  24. Kao W-T, Chang C-L, Lung F-W. 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in a clinical trial. J Affect Disord. 2018;238:597-608.  https://doi.org/10.1016/j.jad.2018.06.035
  25. Sun X, Li C, Zhong X, et al. Influence of psychosocial stress on activation in human brain regions: Moderation by the 5-HTTLPR genetic locus. Physiol Behav. 2020;220:112876. https://doi.org/10.1016/j.physbeh.2020.112876
  26. Eker M, Kitis O, Okur H, et al. Hippocampus Volume Is Associated with Short Variant of 5-HTTLPR Polymorphism in Medication-Free Major Depressive Disorder Patients. Neuropsychobiology. 2011;63:22-28.  https://doi.org/10.1159/000321834
  27. Gafarov VV, Gromova EA, Gagulin IV, et al. Association of sleep disturbances with various polymorphic variants of the 5-HTTLPR gene SNP rs25531 A>G in persons 25—44 years old. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):43-49. (In Russ.). https://doi.org/10.14412/2074-2711-2023-1-43-49
  28. Zoons E, Booij J, Speelman JD, et al. Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms. EJNMMI Res. 2017;7:1-7.  https://doi.org/10.1186/s13550-017-0338-4
  29. Schneck N, Mann JJ, DeLorenzo C, et al. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli. J Affect Disord. 2015;190:494-498.  https://doi.org/10.1016/j.jad.2015.10.047
  30. Li S, Tang J, Gao Y, et al. The serotonin transporter gene variants modulate acute stress-induced hippocampus and dorsomedial prefrontal cortex activity during memory retrieval. PsyCh J. 2019;8:363-377.  https://doi.org/10.1002/pchj.297
  31. Culverhouse RC, Saccone NL, Horton AC, et al. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry. 2017;23:133-142.  https://doi.org/10.1038/mp.2017.44
  32. Gafarov VV, Sukhanov AV, Gromova EA, et al. Stress in the workplace and cognitive functions (population study of the population aged 25—44 years). Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):30-36. (In Russ.). https://doi.org/10.14412/2074-2711-2021-4-30-36
  33. Golimbet VE, Volel BA, Dolzhikov AV, et al. Study of the role of the 5-HTTLPR polymorphism of the serotonin transporter gene in the development of depression in coronary heart disease. Journal of Neurology and Psychiatry S.S. Korsakov. 2012;112(8):63-69. (In Russ.).
  34. Kenna GA. Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: Review of psychopathology and pharmacotherapy. Pharmacogenom Pers Med. 2012;5:19-35.  https://doi.org/10.2147/PGPM.S23462
  35. Tsai SJ, Cheng CY, Yu YW, et al. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet. 2003;123B(1):19-22.  https://doi.org/10.1002/ajmg.b.20026
  36. Wendland JR, Martin BJ, Kruse MR, et al. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry. 2006;11(3):224-226.  https://doi.org/10.1038/sj.mp.4001789

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.